Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ambreen Khawar"'
Autor:
Ambreen Khawar, Elisabeth Eppard, Frank Roesch, Hojjat Ahmadzadehfar, Stefan Kürpig, Michael Meisenheimer, Florian. C. Gaertner, Markus Essler, Ralph. A. Bundschuh
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background Preclinical biodistribution and dosimetric analysis of [177Lu]Lu-DOTAZOL suggest the bisphosphonate zoledronate as a promising new radiopharmaceutical for therapy of bone metastases. We evaluated biodistribution and normal organ a
Externí odkaz:
https://doaj.org/article/f93b70408f4148518e433bc88a9f132d
Publikováno v:
Journal of Radiation and Nuclear Applications. 7:45-49
Autor:
Matthias Haendeler, Ambreen Khawar, Michael Meisenheimer, Hojjat Ahmadzadehfar, Stefan Kürpig, Ralph A. Bundschuh, Markus Essler, Florian Gaertner
Publikováno v:
Radiation
Volume 1
Issue 1
Pages 4-44
Volume 1
Issue 1
Pages 4-44
[68Ga]Ga-RM2 is a promising innovative positron emission tomography (PET) tracer for patients with primary or metastatic prostate carcinoma. This study aims to analyze the biodistribution and radiation dosimetry of [68Ga]Ga-RM2 in five prostate cance
Autor:
Ambreen Khawar, Hojjat Ahmadzadehfar, Stefan Kürpig, Florian. C. Gaertner, Markus Essler, Ralph A. Bundschuh
Publikováno v:
6th International Conference on Radiopharmaceutical Therapy (ICRT 2021) Abstracts.
Publikováno v:
6th International Conference on Radiopharmaceutical Therapy (ICRT 2021) Abstracts.
Autor:
Michael Meisenheimer, Florian Gaertner, Ambreen Khawar, Markus Essler, Elisabeth Eppard, Frank Roesch, Ralph A. Bundschuh, Stefan Kürpig, Hojjat Ahmadzadehfar
Publikováno v:
Annals of Nuclear Medicine. 33:404-413
Pre-clinical studies with gallium-68 zoledronate ([68Ga]Ga-DOTAZOL) have proposed it to be a potent bisphosphonate for PET/CT diagnosis of bone diseases and diagnostic counterpart to [177Lu]Lu-DOTAZOL and [225Ac]Ac-DOTAZOL. This study aims to be the
Autor:
Frank Roesch, Markus Essler, Ralph A. Bundschuh, Stefan Kürpig, Barbara Kreppel, Hojjat Ahmadzadehfar, Florian Gaertner, Michael Meisenheimer, Ambreen Khawar
Publikováno v:
Nuklearmedizin. Nuclear medicine. 59(3)
Autor:
Florian Gaertner, Ambreen Khawar, Jean Phlippe Sinnes, Markus Essler, Frank Roesch, Michael Meisenheimer, Elisabeth Eppard, Stefan Kürpig, Ralph A. Bundschuh, Hojjat Ahmadzadehfar
Publikováno v:
Clinical Nuclear Medicine. 43:486-491
In vivo pharmacokinetic analysis of [Sc]Sc-PSMA-617 was used to determine the normal organ-absorbed doses that may result from therapeutic activity of [Lu]Lu-PSMA-617 and to predict the maximum permissible activity of [Lu]Lu-PSMA-617 for patients wit
Autor:
Barbara Kreppel, Florian C. Gärtner, Ambreen Khawar, Markus Essler, Elisabeth Eppard, Klaus Kopka, Ana de la Fuente, Frank Rösch, Martina Benešová, Ralph A. Bundschuh
Publikováno v:
Theranostics
Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The DOTA-conjugate PSMA-617 has proven high potential in PSMA radioligand the
Autor:
Florian Gaertner, Michael Meisenheimer, Stefan Kürpig, Elisabeth Eppard, Markus Essler, Ambreen Khawar, Frank Roesch, Hojjat Ahmadzadehfar, Ralph A. Bundschuh
Publikováno v:
EJNMMI Research
EJNMMI Research, Vol 9, Iss 1, Pp 1-10 (2019)
EJNMMI Research, Vol 9, Iss 1, Pp 1-10 (2019)
Background Preclinical biodistribution and dosimetric analysis of [177Lu]Lu-DOTAZOL suggest the bisphosphonate zoledronate as a promising new radiopharmaceutical for therapy of bone metastases. We evaluated biodistribution and normal organ absorbed d